Results 11 to 20 of about 1,210 (146)
Ultrasound in Obstetrics &Gynecology, Volume 62, Issue 5, Page 644-652, November 2023., 2023 ABSTRACT Objectives To identify all prediction models for fetal and neonatal outcomes in pregnancies with preterm manifestations of placental insufficiency (gestational hypertension, pre‐eclampsia, HELLP syndrome or fetal growth restriction with its onset before 37 weeks' gestation) and to assess the quality of the models and their performance on ...
D. G. Kleuskens +8 more
wiley +1 more source
Glycosylated fibronectin improves first‐trimester prediction of pre‐eclampsia
Ultrasound in Obstetrics &Gynecology, Volume 62, Issue 4, Page 512-521, October 2023., 2023 ABSTRACT Objective To determine whether maternal serum glycosylated fibronectin (GlyFn) level in the first trimester increases the sensitivity of the Fetal Medicine Foundation (FMF) triple test, which incorporates mean arterial pressure, uterine artery pulsatility index and placental growth factor, when screening for pre‐eclampsia (PE) in an Asian ...
S. Moungmaithong +7 more
wiley +1 more source
Ultrasound in Obstetrics &Gynecology, Volume 60, Issue 3, Page 381-389, September 2022., 2022 ABSTRACT Objective To evaluate the performance of third‐trimester ultrasound for the diagnosis of clinically significant placenta accreta spectrum disorder (PAS) in women with low‐lying placenta or placenta previa. Methods This was a prospective multicenter study of pregnant women aged ≥ 18 years who were diagnosed with low‐lying placenta (< 20 mm from
N. Fratelli +42 more
wiley +1 more source
Routine first‐trimester pre‐eclampsia screening and risk of preterm birth
Ultrasound in Obstetrics &Gynecology, Volume 60, Issue 2, Page 185-191, August 2022., 2022 Abstract Objectives Preterm birth (PTB) is a major public health problem worldwide. It can occur spontaneously or be medically indicated for obstetric complications, such as pre‐eclampsia (PE) or fetal growth restriction. The main objective of this study was to investigate whether there is a shared uteroplacental etiology in the first trimester of ...
V. Giorgione +4 more
wiley +1 more source
Package of measures to reduce the rate of cesarean delivery [PDF]
目的 探讨有效应对剖宫产的措施，降低剖宫产率，保障母婴健康。方法 制定干预剖宫产一揽子措施与实施方案，确保在本院建卡的孕妇相关知识普及率达到100%。将2016年1—8月在本院住院分娩的1882例产妇作为观察组研究对象，将2015年1—8月在本院住院分娩的1564例产妇作为对照组研究对象，分析比较两组产妇剖宫产率的差异。结果 观察组与对照组数据比较，差异有统计学意义 (P<0.05)。结论 通过一揽子干预措施，降低了剖宫产率，保障了母婴健康。Objective: To explore ...
Yang, Hua
core +2 more sources
Pregnancy outcomes in patients with chronic kidney disease：a Meta analysis [PDF]
Objective To systematically evaluate the impact of chronic kidney disease (CKD) on pregnancy outcomes in pregnant patients. Methods Computer searching was conducted within the databases of MEDLINE, EMBASE, WANFANG DATA, China National Knowledge ...
Da-peng Wang +8 more
core +1 more source
Ultrasound in Obstetrics &Gynecology, Volume 66, Issue 5, Page 621-630, November 2025.ABSTRACT Objectives To compare the maternal hemodynamics of Chinese women at low and at high risk for preterm pre‐eclampsia (PE) and assess the differences in hemodynamic parameters between high‐risk women with or without prophylactic aspirin. Methods This was a prospective longitudinal case–control study of 857 Chinese women with a singleton pregnancy
X. Wang +11 more
wiley +1 more source
妊娠高血压产妇使用抗高血压药物及硫酸镁治疗的疗效评估 [PDF]
, 2020 目的： 分析妊娠高血压产妇使用抗高血压药物及硫酸镁治疗的疗效。 方法： 选取我院 2018 年 1 月 ~2019 年 11 月期间收治的80 例妊娠高血压患者参与本文实验调查，分为实验组和对照组。对照组采取硝苯地平药物治疗，实验组采取硝苯地平联合硫酸镁治疗，对比两组患者治疗效果。 结果： 收缩压、舒张压指标对比对照组有明显改善，因此患者采取联合治疗后的血压改善情况较好，两组实验结果对比表示有价值、有统计学意义。实验组患者采用联合药物治疗后，妊娠不良反应发生率低于对照组 ...
德永 计
core +1 more source
Ultrasound in Obstetrics &Gynecology, Volume 65, Issue 5, Page 567-574, May 2025.ABSTRACT Objectives To assess the value of pregnancy‐associated plasma protein‐A (PAPP‐A) in screening for preterm pre‐eclampsia (PE) (delivery < 37 weeks' gestation) measured in maternal blood samples collected before 11 weeks, and to compare the screening performance of PAPP‐A with that of placental growth factor (PlGF) from blood samples collected ...
L. Rode +21 more
wiley +1 more source
人肝癌裸鼠移植瘤株HHC_4、HHC_(15)的分子病理学研究 [PDF]
, 1996 厦门市同安地区已成为中国肝癌死亡率第二的高发区。作者对由来自该地区肝癌病人的人肝癌所建立的裸鼠移植瘤株(HHC_4、HHC_(15)细胞所提取的dnA进行分子生物学研究。应用PCr方法发现了HHC_4、HHC_(15)癌细胞dnA都有HbVdnA整合。通过dnA测序,证明了HHC_4dnA有P53基因第250密码子的C→A突变;HHC_(15)有P53基因第249密码子的g→T突变。这为本地区肝癌死亡率与高HbV感染率和 ...
周红 +5 more
core